Launch Special: 25% Off EVERYTHING! Use Code LAUNCH25 at Checkout!

Need help? Call Or Text us, and a team member will be happy to assist you. +1-786-957-0245

  • Product Usage Notice: This product is intended strictly for research and laboratory use only. It is designated for in vitro testing and experimental purposes. Any use involving human or animal consumption is prohibited by law. All information provided on this website is for educational purposes only. This product must only be handled by licensed, qualified professionals. It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such.
Cagrilintide

Cagrilintide

Cagrilintide is a synthetic long-acting acylated peptide analogue designed to mimic naturally occurring amylin. Research investigations are exploring its interactions with amylin receptors and calcitonin receptor complexes. Studies are examining its biochemical properties in relation to metabolic signaling pathways, gastric physiology, and satiety mechanisms. Scientists continue to investigate its role in metabolic regulation studies. This material is for research purposes only and is not intended for human use.

$80.00

  • Peptides will arrive in a lyophilized (powder) form for maximum stability
  • Order Now, Ships Today
Purchase Peptides

Description

Cagrilintide is a long-acting amylin analogue currently under investigation for the treatment of obesity and type 2 diabetes. As an analogue of the naturally occurring peptide hormone amylin, Cagrilintide mimics its effects on the central nervous system to induce feelings of satiety and reduce food intake. It is being studied as both a monotherapy and in combination with other metabolic drugs, such as the GLP-1 receptor agonist semaglutide. The dual-pronged approach of combining an amylin analogue with a GLP-1 receptor agonist has shown synergistic effects on weight loss in clinical trials. Research has demonstrated that this combination therapy targets multiple pathways involved in appetite regulation and energy homeostasis, leading to more significant and sustained weight reduction than either agent alone. Key research areas for Cagrilintide include its role in long-term weight management, its impact on glycemic control in patients with type 2 diabetes, and its potential cardiovascular benefits. This product is for research purposes only.

CAS: 1415456-99-3
PubChem CID: 167312356
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight: 4409 g/mol
Amino Acid Sequence: Modified 31-amino acid amylin analogue with acylation
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture